Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/eejQCfbwoceXtKbtVbWt

ADVERTISEMENT
January 4, 2013News for medical technology professionals

  Top Story 
  • Abbott's heart stent gains FDA approval
    The FDA has granted Abbott Laboratories approval for its Xience Xpedition system, which the company said is targeted for immediate release in the U.S. The heart stent administers the drug everolimus to aid in the prevention of blood vessel reclogging. Reuters (1/3) LinkedInFacebookTwitterEmail this Story
  Business & Market Trends 
  • Funding round brings in $20 million for Minerva Surgical
    A regulatory filing shows Minerva Surgical has secured $20 million in a recent funding round. The Cupertino, Calif.-based startup is the maker of an endometrial ablation device that treats excessive menstrual bleeding using RF Argon Plasma Energy stored in a balloon. MedCityNews.com (1/3) LinkedInFacebookTwitterEmail this Story
 
  • CardiOx seeks $4 million to support launch of heart defect test
    CardiOx is looking to raise $4 million in a funding round as the company awaits regulatory clearance for its flagship product: a noninvasive test to detect a heart defect called patent foramen ovale. The Columbus, Ohio-based company will use the money to launch the assay during the first half of the year, said CEO Larry Heaton. MedCityNews.com (1/3) LinkedInFacebookTwitterEmail this Story
  International Developments 
  Science & Health 
  • Covidien's device shows promise in venous reflux study
    Covidien said its ClosureFast ablation catheter showed positive results in a multicenter study of European patients with superficial venous reflux who were treated with the device. Of the 233 study participants who were available for evaluation at five years, 95% were found to be cleared of pathological venous reflux and 92% reported full closure of the treated vein. MassDevice.com (Boston) (1/3) LinkedInFacebookTwitterEmail this Story
  Emerging Technologies 
  • Device uses electrical stimulation to treat severe gastric reflux
    EndoStim has created a device that uses electrical stimulation to treat patients with severe gastroesophageal reflux disease. The system, which consists of a pulse generator implanted in the abdomen subcutaneously via laparoscopic surgery, already has marketing approval in Europe. The company is now seeking $12 million to help it pursue FDA approval for the device. MedCityNews.com (1/3) LinkedInFacebookTwitterEmail this Story
  Industry Service Providers 
  Government & Regulatory 
  • FDA gives Alphatec nod on 2 spinal devices
    Alphatec Spine has gained 510(k) clearance from the FDA to market its Pegasus system, an anterior interbody device delivered to the cervical spine without the need for impaction. The agency also cleared the company's ILLICO FS Facet Fixation System, which aids surgeons in stabilizing spinal segments without using rods and screws. BeckersOrthopedicAndSpine.com (1/3) LinkedInFacebookTwitterEmail this Story
AdvaMed News 
  • Medical Device Reimbursement Workshop
    Tuesday, Feb. 26 – Wednesday, Feb. 27
    Sheraton Crystal City, Arlington, Va.
    AdvaMed MTLI’s workshop for medical technology reimbursement professionals will provide the road map to successfully navigate the many potential pitfalls. After an overview of reimbursement issues, the workshop will drill down to coding systems, technology assessments and differences in inpatient and outpatient payment systems. Hear from experts on how to negotiate CMS coverage. Learn how to plan for the new health care reform landscape, deal with comparative effectiveness and manage international reimbursement. Visit MTLI online for more information. LinkedInFacebookTwitterEmail this Story
Learn more about AdvaMed ->About AdvaMed | Join | Courses | Events | Newsroom

 
Position TitleCompany NameLocation
Quality Systems ManagerRoche DiagnosticsIndianapolis, IN
IP Litigation Counsel - 001980Edwards LifesciencesIrvine, CA
Senior Director, Clinical Programs - Transcatheter Heart ValveEdwards LifesciencesIrvine, CA
Click here to view more job listings.

  SmartQuote 
Beware the fury of a patient man."
--John Dryden,
British poet, critic and playwright


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Account Director:  Meryl Harold (202) 407-7828
Job Board:  Jackie Basso (202) 407-7871
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent AdvaMed SmartBrief Issues:   Lead Editor:  Lisa Gough
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information